Showing results (1531-1540 of 3,551) with videos related to
Sort By:
Pageof 356
Thoracic Cancer|May 9, 2023
Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR-433-3p/YWHAZ cascadeChao Yang, Shuo Zhang, Liang Liu, et al.Thoracic Cancer|May 23, 2023
Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behaviorXiaofang Zhu, Jing Wan, Xu You, et al.Thoracic Cancer|August 4, 2020
Role of YES1 amplification in EGFR mutation-positive non-small cell lung cancer: Primary resistance to afatinib in a patientJunyan Tao, Dantong Sun, Helei HouThoracic Cancer|July 16, 2020
Osimertinib for compound EGFR exon 19 deletion/T790M mutated lung squamous cell carcinomaMuYun Peng, QiuYuan Wen, Xia Wu, et al.Thoracic Cancer|July 14, 2020
Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolismLihui Ke, Songping Cui, Shuo Chen, et al.Thoracic Cancer|July 25, 2020
Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancerNobutaka Kataoka, Yusuke Kunimatsu, Yusuke Tachibana, et al.Thoracic Cancer|August 17, 2022
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCCRilan Bai, Lin Jia, Yangyang Gao, et al.Thoracic Cancer|November 8, 2022
Segmentectomy for clinically early-stage primary squamous cell carcinoma of the lungAtsushi Kagimoto, Yasuhiro Tsutani, Yoshihisa Shimada, et al.Thoracic Cancer|November 8, 2022
Anlotinib plus chemotherapy for T790M-negative EGFR-mutant non-sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trialJuan Li, Yuke Tian, Min Zheng, et al.Thoracic Cancer|November 9, 2022
A single-center study of thoracoscopic surgery in the treatment of pediatric mediastinal neurogenic tumorsQiangye Zhang, Tingting Zhou, Peimin Hou, et al.Pageof 356